Conmed (CNMD) Non-Current Assets (2010 - 2026)
Conmed's (CNMD) quarterly Non-Current Assets came in at $1.6 billion in Q2 2026, down 2.76% on a YoY basis from $1.7 billion in Q2 2025, and down 1.2% quarter-over-quarter from $1.6 billion in Q1 2026.
Analysis
Conmed (CNMD) Non-Current Assets (2010 - 2026) Analysis & Trends
Conmed (CNMD) has reported Non-Current Assets for 17 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 2.76% year-over-year to $1.6 billion; the trailing twelve-month figure through Jun 2026 stood at $6.6 billion (down 1.32% YoY), and the FY2025 full-year result was $1.7 billion, down 0.8% from the prior year.
- Non-Current Assets eased to $1.6 billion in Q2 2026 per CNMD's latest filing, from $1.6 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.7 billion in Q3 2022 and bottomed at $1.3 billion in Q1 2022.
- Historically, Non-Current Assets has averaged $1.6 billion across 5 years, with a median of $1.7 billion in 2024.
- The sharpest annual moves came in 2023 and 2026: Non-Current Assets jumped 31.8% in 2023, then dropped 2.76% in 2026.
- Over 5 years, Non-Current Assets stood at $1.7 billion in 2022, then declined by 1.86% to $1.7 billion in 2023, then dropped by 1.08% to $1.7 billion in 2024, then decreased by 0.8% to $1.7 billion in 2025, then retreated by 1.71% to $1.6 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.6 billion, $1.6 billion, and $1.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Conmed | 1.42 Bn | 1.38 Bn | 197.46 Mn | 1.62 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Bn |
| Mar 31, 2026 | 1.64 Bn |
| Dec 31, 2025 | 1.65 Bn |
| Sep 30, 2025 | 1.66 Bn |
| Jun 30, 2025 | 1.67 Bn |
| Mar 31, 2025 | 1.66 Bn |
| Dec 31, 2024 | 1.67 Bn |
| Sep 30, 2024 | 1.67 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.67 Bn |
| Dec 31, 2023 | 1.68 Bn |
| Sep 30, 2023 | 1.70 Bn |
| Jun 30, 2023 | 1.71 Bn |
| Mar 31, 2023 | 1.71 Bn |
| Dec 31, 2022 | 1.72 Bn |
| Sep 30, 2022 | 1.72 Bn |
| Jun 30, 2022 | 1.50 Bn |
| Mar 31, 2022 | 1.30 Bn |
| Dec 31, 2021 | 1.31 Bn |
| Sep 30, 2021 | 1.31 Bn |